Breaking News Instant updates and real-time market news.

CYH

Community Health

$6.33

0.025 (0.40%)

, HCA

HCA Holdings

$78.40

-0.52 (-0.66%)

15:03
01/10/17
01/10
15:03
01/10/17
15:03

Trump presses for immediate repeal, replace of Obamacare, NYT says

Donald Trump on Tuesday pushed lawmakers for a nearly immediate repeal of Obamacare, the New York Times reported, citing statements from the President-elect. Trump demanded a repeal vote "probably some time next week," adding that "the replace will be very quickly or simultaneously, very shortly thereafter... It won't be repeal and then two years later go in with another plan," according to the report. The publication argues that the request is "very likely impossible," as lawmakers are "nowhere close" to agreeing on a replacement. The publication also notes that the request is in clear contradiction of Speaker Paul Ryan's plans. Publicly traded companies in the hospital and healthcare space include Community Health Systems (CYH), HCA Holdings (HCA), LifePoint (LPNT), Tenet (THC), Universal Health Services (UHS), UnitedHealth (UNH), Kindred (KND) and Ventas (VTR). Reference Link

CYH

Community Health

$6.33

0.025 (0.40%)

HCA

HCA Holdings

$78.40

-0.52 (-0.66%)

LPNT

LifePoint

$59.90

0.8 (1.35%)

THC

Tenet

$17.53

0.28 (1.62%)

UHS

Universal Health

$112.41

0.87 (0.78%)

UNH

UnitedHealth

$161.90

-0.05 (-0.03%)

KND

Kindred Healthcare

$7.90

-0.1 (-1.25%)

VTR

Ventas

$61.26

-2.19 (-3.45%)

  • 10

    Jan

  • 17

    Jan

  • 10

    Feb

CYH Community Health
$6.33

0.025 (0.40%)

11/11/16
FBCO
11/11/16
DOWNGRADE
FBCO
Underperform
Community Health downgraded to Underperform from Neutral at Credit Suisse
11/11/16
FBCO
11/11/16
DOWNGRADE
Target $4.25
FBCO
Underperform
Community Health downgraded Underperform on ACA risk at Credit Suisse
As previously reported, Credit Suisse downgraded Molina to Underperform from Neutral and lowered its price target to $4.25 from $7. Analyst Scott Fidel changed his raiting to reflect Affordable Care Act repeal risk and industry high margin profile.
01/03/17
PIPR
01/03/17
INITIATION
Target $6
PIPR
Neutral
Community Health initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Sarah James initiated Community Health with a Neutral and a $6 price target.
12/23/16
LEER
12/23/16
NO CHANGE
LEER
Market Perform
Community Health real estate transaction a 'modest positive,' says Leerink
Leerink analyst Ana Gupte views Community Health's sale and leaseback of ten medical office buildings as a "modest positive." The analyst remains on the sidelines despite the recent selloff given the weaker visibility into the operational outlook, as well as the EBITDA and timing of divestitures. She reiterates a Market Perform rating on the shares.
HCA HCA Holdings
$78.40

-0.52 (-0.66%)

11/09/16
AVON
11/09/16
DOWNGRADE
AVON
Market Perform
HCA Holdings downgraded to Market Perform from Outperform at Avondale
01/03/17
PIPR
01/03/17
INITIATION
Target $81
PIPR
Overweight
HCA Holdings initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Sarah James initiated HCA Holdings with an Overweight and an $81 price target.
11/09/16
MZHO
11/09/16
DOWNGRADE
Target $78
MZHO
Neutral
HCA Holdings downgraded to Neutral on Republican win at Mizuho
As previously reported, Mizuho analyst Sheryl Skolnick downgraded HCA Holdings to Neutral from Buy citing Donald Trump's election and the move to a GOP Congress. Following the election results, Skolnick sees an "extreme risk" for the ACA to be repealed and replaced and for the loss of the Medicaid expansion, both of which she notes have been primary drivers of results for hospitals and health plans. She cut her price target on the stock to $78 from $97.
11/15/16
UBSW
11/15/16
NO CHANGE
Target $90
UBSW
Buy
HCA Holdings share buybacks a strong positive signal, says UBS
UBS analyst A.J. Rice said HCA sent a strong positive signal with its authorization of an additional share repurchase program for up to $2B and he recommends focusing on HCA within the Hospital group while waiting for clarity on ACA in the wake of the election. Rice, who citing HCA's margins, above average growth, cash flow, share repurchases and below average exposure to ACA, keeps a Buy rating and $90 price target on the stock.
LPNT LifePoint
$59.90

0.8 (1.35%)

01/03/17
PIPR
01/03/17
INITIATION
Target $62
PIPR
Neutral
LifePoint initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Sarah James initiated LifePoint with a Neutral and a $62 price target.
11/11/16
FBCO
11/11/16
DOWNGRADE
Target $60
FBCO
Neutral
LifePoint downgraded to Neutral following Trump win at Credit Suisse
As previously reported, Credit Suisse downgraded LifePoint to Neutral from Outperform and lowered its price target to $60 from $70. Analyst Scott Fidel said LifePoint has significantly benefited from the Affordable Care Act and sees significant uncertainty ahead following Trump's victory and the Republican sweep. The analyst said 8%-10% of LifePoint's EBITDA could be at risk, which could be partially offset by improvements at its recently acquired facilities.
11/09/16
AVON
11/09/16
DOWNGRADE
AVON
Market Perform
LifePoint downgraded to Market Perform from Outperform at Avondale
11/11/16
FBCO
11/11/16
DOWNGRADE
FBCO
Neutral
LifePoint downgraded to Neutral from Outperform at Credit Suisse
THC Tenet
$17.53

0.28 (1.62%)

11/10/16
11/10/16
DOWNGRADE

Market Perform
Tenet downgraded to Market Perform at Raymond James
As previously reported, Raymond James downgraded Tenet to Market Perform from Outperform. The firm's analyst said Tenet's valuation appears to be pricing in a "repeal" of ACA while forgetting the "replace" aspect and notes there is not sufficient detail on what Trump's policy proposals on healthcare will look like yet.
11/10/16
RAJA
11/10/16
DOWNGRADE
RAJA
Market Perform
Tenet downgraded to Market Perform from Outperform at Raymond James
01/03/17
PIPR
01/03/17
INITIATION
Target $16
PIPR
Neutral
Tenet initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Sarah James initiated Tenet with a Neutral and a $16 price target.
11/22/16
MZHO
11/22/16
DOWNGRADE
MZHO
Underperform
Tenet downgraded to Underperform from Neutral at Mizuho
Mizuho downgraded Tenet to Underperform citing premium valuation and lack of visibility on what will happen to ACA, Medicaid, and Medicare.
UHS Universal Health
$112.41

0.87 (0.78%)

01/03/17
PIPR
01/03/17
INITIATION
Target $119
PIPR
Neutral
Universal Health initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Sarah James initiated Universal Health with a Neutral and a $119 price target..
12/14/16
12/14/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) downgraded to Neutral from Overweight at JPMorgan with analyst Rod Hall saying the shares are near fair value while the global consumer picture "remains negative." 2. Prudential (PRU) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Nigel Dally saying he recommends taking some profits following the post election surge. 3. Proteon Therapeutics (PRTO) downgraded to Neutral from Outperform at Baird, to Perform from Outperform at Oppenheimer, to Market Perform at JMP Securities, to Hold from Buy at Stifel, to Market Perform at Raymond James, and to Market Perform from Outperform at Cowen. 4. Universal Health (UHS) downgraded to Market Perform from Outperform at Raymond James with analyst John Ransom saying he sees increasing political risk following Senator Grassley's letter to the inspector general regarding details of the current federal investigation into Universal Health and thinks it's possible that increased political scrutiny could result in more caution and/or red tape into the admissions process, either from self-policing or externally. 5. Lincoln National (LNC) downgraded to Equal Weight from Overweight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/14/16
12/14/16
DOWNGRADE

Market Perform
Universal Health downgraded on increased political risk at Raymond James
As previously reported, Raymond James downgraded Universal Health to Market Perform from Outperform. Analyst John Ransom sees increasing political risk following Senator Grassley's letter to the inspector general regarding details of the current federal investigation into Universal Health and thinks it's possible that increased political scrutiny could result in more caution and/or red tape into the admissions process, either from self-policing or externally.
12/14/16
RAJA
12/14/16
DOWNGRADE
RAJA
Market Perform
Universal Health downgraded to Market Perform from Outperform at Raymond James
UNH UnitedHealth
$161.90

-0.05 (-0.03%)

01/03/17
PIPR
01/03/17
INITIATION
Target $188
PIPR
Overweight
UnitedHealth initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Sarah James commenced co-coverage on UnitedHealth with an Overweight and a $188 price target, up from $155. Piper Jaffray's Healthcare IT Sr. Analyst, Sean Wieland, will continue to focus on Optum while James will provide a refreshed look at the managed care portion. James believes UnitedHealth will grow earnings above peers driven by capital deployment, best in class cost control, which drives market share gains, international expansion, and above consensus growth in Optum as it builds out relationships with existing customers and increasingly beats large peers on new contract wins.
12/23/16
JEFF
12/23/16
NO CHANGE
Target $89
JEFF
Buy
Jefferies expects Magellan to rally today on Virginia win
Jefferies analyst David Styblo expects shares of Magellan Health (MGLN) to rally today on the news that the company was one of seven managed care organizations selected for the $3.5B Virginia Managed Long Term Services and Supports initiative. Besides the financial benefit, the award shows Magellan can compete for business serving acute populations, Styblo tells investors in a research note titled "Santa Delivers Early for MGLN in Virginia." The other six winners include Aetna (AET), Anthem (ANTM), Humana (HUM), UnitedHealth (UNH), Optima Health and Virginia Premier, the analyst notes. Styblo reiterates a Buy rating on Magellan with an $89 price target.
12/01/16
FBCO
12/01/16
NO CHANGE
FBCO
Outperform
UnitedHealth policy for Exondys 51 a positive for Sarepta, says Credit Suisse
Credit Suisse analyst Alethia Young noted that Sarepta (SRPT) shares have been weak since UnitedHealth (UNH) posted its medical benefit policy for the company's DMD drug Exondys 51, but she doesn't see a reason for the weakness. She doesn't think encouraging home infusions limits access and believes the requirement for an every 6 month reauthorization is neither "prohibitive nor concerning" as it is standard with expensive rare disease treatments. She sees the policy as a positive for Sarepta, as having more payers supporting Exondys reimbursement makes it hard for other payers not to do so, and keeps an Outperform rating on Sarepta shares.
12/07/16
CANT
12/07/16
UPGRADE
CANT
Buy
UnitedHealth upgraded to Buy from Hold at Cantor
KND Kindred Healthcare
$7.90

-0.1 (-1.25%)

11/08/16
STFL
11/08/16
DOWNGRADE
STFL
Sell
Kindred Healthcare downgraded on Q3 miss, guidance cut at Stifel
As noted earlier, Stifel downgraded Kindred to Sell from Hold. Analyst Chad Vanacore downgraded the stock based on the company's weaker than expected results and guidance reduction. Target to $5 from $10.
11/08/16
STFL
11/08/16
DOWNGRADE
STFL
Sell
Kindred Healthcare downgraded to Sell from Hold at Stifel
11/10/16
RBCM
11/10/16
DOWNGRADE
RBCM
Sector Perform
Kindred Healthcare downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst Frank Morgan downgraded Kindred after the company lowered its fiscal 2016 guidance. Morgan says that the guidance cut was caused by pressures on the company's SNF segment. Morgan adds that the company's planned exit from its SNF business, along with regulatory pressures, will produce "significant uncertainties and likely bumpiness." He thinks that the stock could rebound in the near-term, but he expects it to subsequently be "range-bound" for "the next year or so." Target to $9 from $16.
VTR Ventas
$61.26

-2.19 (-3.45%)

11/21/16
MZHO
11/21/16
DOWNGRADE
MZHO
Neutral
Ventas downgraded to Neutral from Buy at Mizuho
11/10/16
BMOC
11/10/16
DOWNGRADE
BMOC
Underperform
Ventas downgraded on Trump victory at BMO Capital
As noted earlier, BMO Capital downgraded Ventas to Underperform from Market Perform. Analyst John Kim says that the expected repeal of the ACA will hurt hospitals and consequently medical office building demand. The analyst says that Ventas has high exposure to the latter. Target $55.
11/11/16
HDLY
11/11/16
UPGRADE
HDLY
Neutral
Ventas upgraded to Neutral from Underperform at Hilliard Lyons
01/03/17
JEFF
01/03/17
DOWNGRADE
Target $65
JEFF
Hold
Ventas downgraded to Hold from Buy at Jefferies
Jefferies analyst Omotayo Okusanya downgraded Ventas to Hold saying potential repeal of the Affordable Care Act creates headwinds for the company's hospital portfolio. Rising interest rates are also an additional headwind, the analyst contends. He views a Trump presidency as bad for hospitals and lowered his price target for Ventas shares to $65 from $75.

TODAY'S FREE FLY STORIES

NVCR

Novocure

$21.50

-0.1 (-0.46%)

18:27
09/24/17
09/24
18:27
09/24/17
18:27
Hot Stocks
Combination of Novocure Optune with Temozolomide demonstrates five-year survival »

Novocure announced today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$102.40

-0.09 (-0.09%)

, CMCSA

Comcast

$38.10

0.63 (1.68%)

17:10
09/24/17
09/24
17:10
09/24/17
17:10
Hot Stocks
Box Office Battle: 'Kingsman: The Golden Circle' easily wins weekend »

"Kingsman: The…

TWX

Time Warner

$102.40

-0.09 (-0.09%)

CMCSA

Comcast

$38.10

0.63 (1.68%)

CMCSK

Comcast

SNE

Sony

$37.50

0.04 (0.11%)

FOX

21st Century Fox

$26.43

0.1 (0.38%)

FOXA

21st Century Fox

$26.88

0.12 (0.45%)

LGF.A

Lionsgate

$31.49

0.24 (0.77%)

DIS

Disney

$98.60

-0.29 (-0.29%)

VIAB

Viacom

$27.64

0.24 (0.88%)

VIA

Viacom

$38.00

-0.2 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 29

    Sep

  • 22

    Oct

  • 26

    Oct

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

16:41
09/24/17
09/24
16:41
09/24/17
16:41
Periodicals
Amazon affiliate to buy stake in Indian retailer Shoppers Stop, Reuters says »

An affiliate of Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

, GOOG

Alphabet

$928.53

-3.92 (-0.42%)

16:37
09/24/17
09/24
16:37
09/24/17
16:37
Periodicals
Internet giants on the defensive in Washington, Reuters says »

Internet giants,…

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

  • 29

    Nov

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

, UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

16:25
09/24/17
09/24
16:25
09/24/17
16:25
Periodicals
Opposition to new 'Obamacare' repeal bill grows, Reuters reports »

The new proposal by…

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

CNC

Centene

$92.22

1.48 (1.63%)

WCG

WellCare

$167.16

1.1 (0.66%)

CI

Cigna

$182.74

0.61 (0.33%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

AET

Aetna

$153.57

0.18 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

SAP

SAP

$110.27

0.64 (0.58%)

16:11
09/24/17
09/24
16:11
09/24/17
16:11
Hot Stocks
SAP announces acquisition of Gigya »

SAP has announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TATT

TAT Technologies

$10.70

0.05 (0.47%)

, BA

Boeing

$256.45

0.41 (0.16%)

16:03
09/24/17
09/24
16:03
09/24/17
16:03
Hot Stocks
TAT Technologies awarded APU MRO contract for fleet of Boeing, Airbus »

TAT Technologies (TATT),…

TATT

TAT Technologies

$10.70

0.05 (0.47%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

GM

General Motors

$39.42

0.32 (0.82%)

11:43
09/23/17
09/23
11:43
09/23/17
11:43
Periodicals
GM to eliminate shift at Tennessee SUV plant on 'moderating' sales, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.25

0.19 (0.35%)

11:34
09/23/17
09/23
11:34
09/23/17
11:34
Periodicals
Wells Fargo hires law firm to prepare CEO for Senate appearance, Reuters says »

Wells Fargo has hired law…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 13

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

EADSY

Airbus

$23.06

-0.01 (-0.04%)

11:27
09/23/17
09/23
11:27
09/23/17
11:27
Periodicals
Airbus in talks to sell all or part of Premium Aerotec, Reuters says »

Airbus is said to be in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$102.11

0.56 (0.55%)

11:06
09/23/17
09/23
11:06
09/23/17
11:06
Hot Stocks
Quest Diagnostics 'disappointed' with proposed PAMA 2018 Medicare payment rates »

Quest Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

IRBT

iRobot

$76.14

-3.8 (-4.75%)

10:58
09/23/17
09/23
10:58
09/23/17
10:58
Periodicals
iRobot suffering after onslaught of SharkNinja cheaper models, Barron's says »

In a follow up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47
Periodicals
Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says »

As everyday items get…

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UTX

United Technologies

$115.01

0.51 (0.45%)

, COL

Rockwell Collins

$130.48

0.09 (0.07%)

10:42
09/23/17
09/23
10:42
09/23/17
10:42
Periodicals
Major aircraft makers, suppliers face off, Barron's says »

While United Technologies…

UTX

United Technologies

$115.01

0.51 (0.45%)

COL

Rockwell Collins

$130.48

0.09 (0.07%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

GPRO

GoPro

$10.75

-0.19 (-1.74%)

10:33
09/23/17
09/23
10:33
09/23/17
10:33
Periodicals
Key events may create 'short squeeze' in GoPro stock, Barron's says »

GoPro, a heavily shorted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.91

0.18 (0.61%)

, RACE

Ferrari

$113.47

-0.1 (-0.09%)

10:17
09/23/17
09/23
10:17
09/23/17
10:17
Periodicals
Honda $200,000 Acura NSX lacks Ferrari 'raw appeal,' Barron's says »

Acura, Honda's (HMC)…

HMC

Honda

$29.91

0.18 (0.61%)

RACE

Ferrari

$113.47

-0.1 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.16

0.19 (0.40%)

10:07
09/23/17
09/23
10:07
09/23/17
10:07
Periodicals
Oracle shares could return 20% in a year, Barron's says »

Oracle is a latecomer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.96

1.14 (1.97%)

09:59
09/23/17
09/23
09:59
09/23/17
09:59
Periodicals
Six Flags may have peaked, Barron's says »

Investors have had an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

, AVXS

AveXis

$92.11

-4.03 (-4.19%)

09:51
09/23/17
09/23
09:51
09/23/17
09:51
Periodicals
Gene therapy may be nearing 'major breakthrough,' Baron's says »

Gene therapy is rapidly…

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

  • 22

    Sep

AET

Aetna

$153.57

0.18 (0.12%)

, ANTM

Anthem

$182.86

-0.64 (-0.35%)

09:25
09/23/17
09/23
09:25
09/23/17
09:25
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

AOBC

American Outdoor Brands

$15.01

-0.15 (-0.99%)

RGR

Sturm, Ruger

$51.00

-1.85 (-3.50%)

WMT

Wal-Mart

$79.53

-0.48 (-0.60%)

PEP

PepsiCo

$111.85

-0.95 (-0.84%)

TGT

Target

$58.99

0.66 (1.13%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

TWTR

Twitter

$17.61

0.03 (0.17%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 22

    Oct

  • 24

    Oct

  • 08

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

INSE

Inspired Entertainment

$13.60

0.3 (2.26%)

17:38
09/22/17
09/22
17:38
09/22/17
17:38
Hot Stocks
Inspired Entertainment COO Wilson leaving by reason of redundancy »

On September 21, Inspired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.